MktsMarkets

BriaCell Therapeutics Corp.
NASDAQ: BCTXKey statistics
BCTX News
Stories mentioning BCTX from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q2 '26Apr 30 | Q1 '26Jan 31 | Q4 '25Oct 31 | Q3 '25Jul 31 | Q2 '25Apr 30 | Q1 '25Jan 31 | Q4 '24Oct 31 | Q3 '24Jul 31 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 5,967 | 6,054 | 6,684 | 7,111 | 4,810 | 5,685 | 3,665 | 4,406 |
| Sales General & Admin | ||||||||
| Total Operating Expenses | 7,621 | 7,531 | 8,323 | 8,555 | 6,328 | 7,169 | 5,153 | 5,768 |
| Operating Income (Loss) | (7,621) | (7,531) | (8,323) | (8,555) | (6,328) | (7,169) | (5,153) | (5,768) |
| Interest Income | 219.00 | 106.00 | 48.00 | 33.00 | 27.00 | 47.00 | 13.00 | (1.00) |
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (7,165) | (7,222) | (8,198) | (8,092) | (6,127) | (6,291) | (5,802) | (1,214) |
| Earnings Per Share (Basic) | (0.99) | (2.58) | (4.35) | (19.13) | (16.42) | (23.31) | (32.67) | (11.04) |
| Earnings Per Share (Diluted) | (0.99) | (2.58) | (4.35) | (19.13) | (16.42) | (23.31) | (32.67) | (11.04) |
| Weighted Average Shares Outstanding (Basic) | 7,250 | 2,802 | 1,884 | 423.00 | 373.00 | 270.00 | 178.00 | 110.00 |
| Weighted Average Shares Outstanding (Diluted) | 7,250 | 2,802 | 1,884 | 423.00 | 373.00 | 270.00 | 178.00 | 110.00 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BCTX
BriaCell Therapeutics Corp. (NASDAQ: BCTX) is a stock listed on the Nasdaq Stock Market under the ticker symbol BCTX. It last traded at $3.19 (Nov 4, 2026, 4:00 PM ET), up 6.0% on the day. That gives BriaCell Therapeutics a market capitalisation of $36.7M.
Over the past 52 weeks BCTX has traded between $3.68 and $18.00.
For the quarter ended Apr 30, 2026 it reported a net loss of $7.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Apr 30, 2026 | — | -$7.2M |
| Jan 31, 2026 | — | -$7.2M |
| Oct 31, 2025 | — | -$8.2M |
| Jul 31, 2025 | — | -$8.1M |
From BriaCell Therapeutics’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…